Veracyte Inc. (VCYT)
Veracyte Statistics
Share Statistics
Veracyte has 77.94M shares outstanding. The number of shares has increased by 1.96% in one year.
| Shares Outstanding | 77.94M |
| Shares Change (YoY) | 1.96% |
| Shares Change (QoQ) | 0.57% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 76.84M |
| Failed to Deliver (FTD) Shares | 24 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 5.11M, so 6.56% of the outstanding shares have been sold short.
| Short Interest | 5.11M |
| Short % of Shares Out | 6.56% |
| Short % of Float | 7.31% |
| Short Ratio (days to cover) | 4.47 |
Valuation Ratios
The PE ratio is 127.32 and the forward PE ratio is 46.04. Veracyte's PEG ratio is -0.98.
| PE Ratio | 127.32 |
| Forward PE | 46.04 |
| PS Ratio | 6.89 |
| Forward PS | 3.7 |
| PB Ratio | 2.61 |
| P/FCF Ratio | 48.16 |
| PEG Ratio | -0.98 |
Enterprise Valuation
Veracyte has an Enterprise Value (EV) of 2.88B.
| EV / Sales | 6.47 |
| EV / EBITDA | 58.63 |
| EV / EBIT | 38.42 |
| EV / FCF | 45.21 |
Financial Position
The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.73 |
| Quick Ratio | 4.46 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 1.03 |
| Debt / FCF | 0.8 |
| Interest Coverage | 8071 |
Financial Efficiency
Return on Equity is 2.05% and Return on Invested Capital is 1.23%.
| Return on Equity | 2.05% |
| Return on Assets | 1.86% |
| Return on Invested Capital | 1.23% |
| Revenue Per Employee | $540.98K |
| Profits Per Employee | $29.29K |
| Employee Count | 824 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 6.79 |
Taxes
| Income Tax | 1.61M |
| Effective Tax Rate | 6.24% |
Stock Price Statistics
The stock price has increased by 55.85% in the last 52 weeks. The beta is 2.04, so Veracyte's price volatility has been higher than the market average.
| Beta | 2.04 |
| 52-Week Price Change | 55.85% |
| 50-Day Moving Average | 32.66 |
| 200-Day Moving Average | 34.73 |
| Relative Strength Index (RSI) | 49.97 |
| Average Volume (20 Days) | 977.43K |
Income Statement
In the last 12 months, Veracyte had revenue of 445.76M and earned 24.14M in profits. Earnings per share was 0.31.
| Revenue | 445.76M |
| Gross Profit | 298.14M |
| Operating Income | 16.14M |
| Net Income | 24.14M |
| EBITDA | 49.2M |
| EBIT | 25.75M |
| Earnings Per Share (EPS) | 0.31 |
Balance Sheet
The company has 239.09M in cash and 50.74M in debt, giving a net cash position of 188.35M.
| Cash & Cash Equivalents | 239.09M |
| Total Debt | 50.74M |
| Net Cash | 188.35M |
| Retained Earnings | -443.98M |
| Total Assets | 1.3B |
| Working Capital | 293.63M |
Cash Flow
In the last 12 months, operating cash flow was 75.1M and capital expenditures -11.29M, giving a free cash flow of 63.81M.
| Operating Cash Flow | 75.1M |
| Capital Expenditures | -11.29M |
| Free Cash Flow | 63.81M |
| FCF Per Share | 0.82 |
Margins
Gross margin is 66.88%, with operating and profit margins of 3.62% and 5.41%.
| Gross Margin | 66.88% |
| Operating Margin | 3.62% |
| Pretax Margin | 5.78% |
| Profit Margin | 5.41% |
| EBITDA Margin | 11.04% |
| EBIT Margin | 3.62% |
| FCF Margin | 14.31% |
Dividends & Yields
VCYT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 0.79% |
| FCF Yield | 2.08% |
Analyst Forecast
The average price target for VCYT is $44, which is 38.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $44 |
| Price Target Difference | 38.8% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
Scores
| Altman Z-Score | 12.79 |
| Piotroski F-Score | 7 |